Amplia Therapeutics Limited

OTCPK:INNM.F Stock Report

Market Cap: US$18.5m

Amplia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:INNM.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Dec 24BuyUS$50,028Jane BellIndividual695,652US$0.072
20 Dec 24BuyUS$78,169Robert PeachIndividual1,086,957US$0.072
20 Dec 24BuyUS$25,014Christopher BurnsIndividual347,826US$0.072
20 Dec 24BuyUS$50,028Warwick TongIndividual695,652US$0.072
25 Nov 24BuyUS$827,804Acorn Capital LimitedCompany11,330,840US$0.076
15 Nov 24SellUS$267,446Acorn Capital LimitedCompany3,522,893US$0.094
06 Nov 24BuyUS$65,689Allan MossIndividual869,562US$0.076
04 Nov 24BuyUS$1,319,165Platinum Investment Management LimitedCompany17,391,304US$0.076
09 Aug 24SellUS$273,339Platinum Investment Management LimitedCompany4,164,100US$0.092
06 Aug 24SellUS$144,905Pengana Capital Ltd.Company1,700,000US$0.085
19 Jun 24BuyUS$30,352Robert PeachIndividual827,268US$0.037
15 May 24BuyUS$29,780Jane BellIndividual810,190US$0.037
15 May 24BuyUS$198,083Allan MossIndividual5,389,000US$0.037
15 May 24BuyUS$22,667Christopher BurnsIndividual616,672US$0.037
15 May 24BuyUS$69,838Robert PeachIndividual1,900,005US$0.037
08 Apr 24SellUS$49,064Platinum Investment Management LimitedCompany911,770US$0.054

Insider Trading Volume

Insider Buying: INNM.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INNM.F?
Owner TypeNumber of SharesOwnership Percentage
Public Companies00%
Private Companies12,369,1843.57%
Hedge Funds51,183,32314.8%
Institutions56,283,17716.2%
Individual Insiders60,171,87817.4%
General Public166,508,04948.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 78.6%.

Top Shareholders

Top 23 shareholders own 51.95% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
Platinum Investment Management Limited
51,183,323US$2.7m44.8%0.09%
7.96%
Acorn Capital Limited
27,583,089US$1.5m174%4.3%
5.69%
Allan Moss
19,731,062US$1.1m4.61%no data
4.39%
Pengana Capital Group Limited
15,200,044US$813.2k0%1.79%
3.9%
Pengana Capital Ltd.
13,500,044US$722.3k-11.2%1.48%
1.58%
Robert Peach
5,478,990US$293.1k24.8%no data
1.41%
Christian Behrenbruch
4,885,323US$261.4k0%no data
1.17%
Christopher Burns
4,068,617US$217.7k9.35%no data
1.14%
Ctx Crc Ltd
3,940,579US$210.8k0%no data
1.07%
Warwick Tong
3,711,899US$198.6k23.1%no data
1.02%
Jane Bell
3,531,316US$188.9k-12%no data
0.9%
Heh Entreprises Pty Ltd
3,102,500US$166.0k0%no data
0.81%
Anthony Martin
2,820,323US$150.9k0%no data
0.78%
J&J Stuart Pty Ltd
2,700,000US$144.5k0%no data
0.76%
Ravinna Pty Ltd
2,626,105US$140.5k0%no data
0.7%
Sharon Lewis
2,430,000US$130.0k0%no data
0.7%
Robert Greenslade
2,412,500US$129.1k0%no data
0.64%
Nicholas McDonald
2,216,673US$118.6k0%no data
0.64%
Mark Devlin
2,215,237US$118.5k0%no data
0.56%
Andrew Podolak
1,925,000US$103.0k0%no data
0.48%
Mark Sullivan
1,661,428US$88.9k0%no data
0.44%
Michael Whiting
1,541,755US$82.5k0%no data
0.44%
Tracey Whiting
1,541,755US$82.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:54
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amplia Therapeutics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution